RAD50 mutation
|
Solid Tumor
|
RAD50 mutation
|
Solid Tumor
|
Immunotherapy Sensitive: B - Late Trials
|
Immunotherapy Sensitive: B - Late Trials
|
RAD50 mutation
|
Small Cell Lung Cancer
|
RAD50 mutation
|
Small Cell Lung Cancer
|
olaparib Sensitive: C2 – Inclusion Criteria
|
olaparib Sensitive: C2 – Inclusion Criteria
|
RAD50 mutation
|
Colon Cancer
|
RAD50 mutation
|
Colon Cancer
|
Immunotherapy Sensitive: C3 – Early Trials
|
Immunotherapy Sensitive: C3 – Early Trials
|
RAD50 mutation
|
Prostate Cancer
|
RAD50 mutation
|
Prostate Cancer
|
olaparib Sensitive: C3 – Early Trials
|
olaparib Sensitive: C3 – Early Trials
|